Side by side

Latent-Y vs LatentLabs

Compare what each tool does, what it costs, and how it fits your workflow.

Designed for
Design antibodies from text prompts in hours, not weeks.
Lab-ready protein binders in seconds.
Primary task
Protein design
Protein design
Pricing
Unknown
Unknown
Pricing details
Not documented — check the provider
Not documented — check the provider
Billing cycle
Not documented
Not documented
API access
Not documented
Not documented
Platforms
Web
Web
Integrations
Not documented
X / Twitter
Source rating
No rating recorded
No rating recorded
Catalog views
129
187
Estimated monthly traffic
—
—
Catalog imported
8 Sep 2026
8 Sep 2026
Listed strengths
  • Accelerates drug discovery
  • Designs antibodies from text
  • Autonomous creation of antibodies
  • Runs multiple design campaigns
  • Faster design campaign results
  • Designs antibodies, macrocycles, mini-proteins
  • Reports picomolar binding affinity
  • Experimentally lab-validated, not just predicted
  • Emphasis on drug-like, developable properties
  • Published technical reports (arXiv)
Listed limitations
  • Complex to setup
  • Limited accessibility
  • Only works within Latent Labs
  • Needs expert biotechnology knowledge
  • Difficulty in integrating with other workflows
  • Dual-use biosecurity dimension
  • Researcher/pharma audience only
  • No public pricing (tiered, gated)
  • Vendor-reported metrics need independent validation
  • Requires deep domain expertise

← Latent-Y LatentLabs →